Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
7.16
+0.11 (1.56%)
Feb 5, 2025, 11:10 AM EST - Market open
Pulmatrix Employees
Pulmatrix had 22 employees as of December 31, 2023. The number of employees decreased by 7 or -24.14% compared to the previous year.
Employees
22
Change (1Y)
-7
Growth (1Y)
-24.14%
Revenue / Employee
$454,773
Profits / Employee
-$438,909
Market Cap
26.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PULM News
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - Accesswire
- 2 months ago - PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM - Business Wire
- 3 months ago - Pulmatrix and Cullgen Announce Proposed Merger - PRNewsWire
- 3 months ago - Pulmatrix Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 6 months ago - Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 9 months ago - Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation - PRNewsWire
- 9 months ago - Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) - PRNewsWire
- 9 months ago - Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire